نتایج جستجو برای: fluoroquinolone

تعداد نتایج: 3959  

Journal: :Antimicrobial agents and chemotherapy 2009
Miika Bergman Solja T Nyberg Pentti Huovinen Pirkko Paakkari Antti J Hakanen

During a 9-year study period from 1997 through 2005, the association between antimicrobial resistance rates in Escherichia coli and outpatient antimicrobial consumption was investigated in 20 hospital districts in Finland. A total of 754,293 E. coli isolates, mainly from urine samples, were tested for antimicrobial resistance in 26 clinical microbiology laboratories. The following antimicrobial...

Journal: :Journal of medical microbiology 2004
Shigeru Fujimura Seiichi Kato Kazuie Iinuma Akira Watanabe

Resistance to antibiotics, especially clarithromycin, is the major cause of the failure to eradicate Helicobacter pylori. There are few studies in children concerning fluoroquinolone activity against H. pylori. Primary resistance to antibiotics including fluoroquinolones was studied in 55 H. pylori strains isolated from Japanese children. DNA sequences of the gyrA gene in fluoroquinolone-resist...

2016
Duy Pham Thanh Abhilasha Karkey Sabina Dongol Nhan Ho Thi Corinne N Thompson Maia A Rabaa Amit Arjyal Kathryn E Holt Vanessa Wong Nga Tran Vu Thieu Phat Voong Vinh Tuyen Ha Thanh Ashish Pradhan Saroj Kumar Shrestha Damoder Gajurel Derek Pickard Christopher M Parry Gordon Dougan Marcel Wolbers Christiane Dolecek Guy E Thwaites Buddha Basnyat Stephen Baker

The interplay between bacterial antimicrobial susceptibility, phylogenetics and patient outcome is poorly understood. During a typhoid clinical treatment trial in Nepal, we observed several treatment failures and isolated highly fluoroquinolone-resistant Salmonella Typhi (S. Typhi). Seventy-eight S. Typhi isolates were genome sequenced and clinical observations, treatment failures and fever cle...

Journal: :Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006
Pierre Charbonneau Jean-Jacques Parienti Pascal Thibon Michel Ramakers Cédric Daubin Damien du Cheyron Guy Lebouvier Xavier Le Coutour Roland Leclercq

BACKGROUND We investigated the possible association between fluoroquinolone use and the rate of methicillin-resistant Staphylococcus aureus (MRSA) recovery from consecutive hospitalized patients. METHODS We conducted a nonrandomized, prospective, controlled interventional "fluoroquinolone-free" study at 4 large teaching hospitals in northwest France, catering to a total of 5,882,600 persons. ...

Journal: :Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007
Jennifer M Nelson Tom M Chiller John H Powers Frederick J Angulo

Campylobacter species cause 1.4 million infections each year in the United States. Fluoroquinolones (e.g., ciprofloxacin) are commonly used in adults with Campylobacter infection and other infections. Fluoroquinolones (e.g., enrofloxacin) are also used in veterinary medicine. Human infections with fluoroquinolone-resistant Campylobacter species have become increasingly common and are associated...

Journal: :Antimicrobial agents and chemotherapy 1998
M Oethinger I Podglajen W V Kern S B Levy

The contribution of regulatory genes to fluoroquinolone resistance was studied with clinical Escherichia coli strains bearing mutations in gyrA and parC and with different levels of fluoroquinolone resistance. Expression of marA and soxS was evaluated by Northern blot analysis of isolates that demonstrated increased organic solvent tolerance, a phenotype that has been linked to overexpression o...

2011
Louis C Remynse Patrick J Sweeney Kevin A Brewton Jay M Lonsway

Infectious complications related to prostate ultrasound and biopsy have increased in the past decade with the emergence of increasing fluoroquinolone bacterial resistance. We investigated the addition of intravenous (iv) piperacillin/tazobactam immediately prior to prostate ultrasound and biopsy with standard fluoroquinolone prophylaxis to determine if it would decrease the incidence of serious...

Journal: :Antimicrobial agents and chemotherapy 2011
Samir N Patel Allison McGeer Roberto Melano Gregory J Tyrrell Karen Green Dylan R Pillai Donald E Low

Ciprofloxacin, the first fluoroquinolone to be used to treat lower respiratory tract infections (LRTI), demonstrates poor potency against Streptococcus pneumoniae, and its use has been associated with the emergence of resistance. During the last decade, fluoroquinolones with enhanced in vitro activity against S. pneumoniae have replaced ciprofloxacin for the treatment of LRTI. Here, we analyzed...

2006
Gregory M. Sterne Michael L. Richardson Bill H. Warren

Tendonitis and tendon rupture are rare but recognized complications of fluoroquinolone therapy. Most reports of this problem have appeared in the rheumatology and pharmacology literature, and this topic has received little attention in the radiologic literature. We report two cases of fluoroquinolone-induced tendinopathy and describe their magnetic resonance (MR) and sonographic findings. Altho...

2011
Marzieh Aligholi Akbar Mirsalehian Shahnaz Halimi Hossein Imaneini Morovat Taherikalani Fereshteh Jabalameli Parisa Asadollahi Babak Mohajer Alireza Abdollahi Mohammad Emaneini

BACKGROUND Fluoroquinolones are broad-spectrum antibiotics widely used in the treatment of bacterial infections such as Staphylococcus aureus isolates. Resistance to these antibiotics is increasing. MATERIAL/METHODS The occurrence of mutations in the grlA and gyrA loci were evaluated in 69 fluoroquinolone-resistant S. aureus isolates from 2 teaching hospitals of Tehran University of Medical S...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید